Cite
HARVARD Citation
Shinde, V. et al. (2022). Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial. Lancet infectious diseases. 22 (1), pp. 73-84. [Online].